How does atorvastatin's hmg coa reductase inhibition compare to lipitor's in terms of potency?

Does atorvastatin inhibit HMG‑CoA reductase differently than Lipitor?

Lipitor is a brand name for atorvastatin. Because Lipitor contains the same active drug (atorvastatin), the HMG‑CoA reductase inhibition potency is the same for both terms when the dose is the same.[1]

How is potency compared in practice for atorvastatin (Lipitor)?

Potency is compared by the effect of the drug on the pathway it controls—most commonly measured by how strongly it lowers LDL cholesterol. Since both names refer to the same active ingredient, the expected lipid-lowering potency at a given atorvastatin dose is the same whether you call it “atorvastatin” or “Lipitor.”[1]

What changes potency if the name changes?

Only factors other than the brand name can change the effective inhibition you get, such as:
- the specific atorvastatin dose (mg) taken,
- how the formulation is administered (immediate vs extended release, if applicable),
- patient-specific factors affecting drug response.
Brand naming itself (Lipitor vs generic atorvastatin) does not change the mechanism or intrinsic potency for HMG‑CoA reductase inhibition.[1]

Bottom line

Atorvastatin’s HMG‑CoA reductase inhibition potency is the same as Lipitor’s because Lipitor is simply atorvastatin marketed under a brand name.[1]

Sources:
[1] https://www.drugs.com/liipitor.html